Kyncl JJ - Search Results

1

Conformationally defined adrenergic agents. 4. 1-(aminomethyl)phthalans: synthesis and pharmacological consequences of the phthalan ring oxygen atom.

DeBernardis JF, Arendsen DL, Kyncl JJ, Kerkman DJ. DeBernardis JF, et al. Among authors: kyncl jj. J Med Chem. 1987 Jan;30(1):178-84. doi: 10.1021/jm00384a030. J Med Chem. 1987. PMID: 2879916

2

Conformationally defined adrenergic agents. 1. Design and synthesis of novel alpha 2 selective adrenergic agents: electrostatic repulsion based conformational prototypes.

DeBernardis JF, Kerkman DJ, Winn M, Bush EN, Arendsen DL, McClellan WJ, Kyncl JJ, Basha FZ. DeBernardis JF, et al. Among authors: kyncl jj. J Med Chem. 1985 Oct;28(10):1398-404. doi: 10.1021/jm00148a005. J Med Chem. 1985. PMID: 2864446

3

Conformationally defined adrenergic agents. 2. Catechol imidazoline derivatives: biological effects at alpha 1 and alpha 2 adrenergic receptors.

DeBernardis JF, Kyncl JJ, Basha FZ, Arendsen DL, Martin YC, Winn M, Kerkman DJ. DeBernardis JF, et al. Among authors: kyncl jj. J Med Chem. 1986 Apr;29(4):463-7. doi: 10.1021/jm00154a006. J Med Chem. 1986. PMID: 2870187

4

Conformationally defined adrenergic agents. 5. Resolution, absolute configuration, and pharmacological characterization of the enantiomers of 2-(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthyl)imidazoline: a potent agonist at alpha-adrenoceptors.

DeBernardis JF, Kerkman DJ, Arendsen DL, Buckner SA, Kyncl JJ, Hancock AA. DeBernardis JF, et al. Among authors: kyncl jj. J Med Chem. 1987 Jun;30(6):1011-7. doi: 10.1021/jm00389a009. J Med Chem. 1987. PMID: 2884313

5

Conformationally defined adrenergic agents. 3. Modifications to the carbocyclic ring of 5,6-dihydroxy-1-(2-imidazolinyl)tetralin: improved separation of alpha 1 and alpha 2 adrenergic activities.

DeBernardis JF, Winn M, Arendsen DL, Kerkman DJ, Kyncl JJ. DeBernardis JF, et al. Among authors: kyncl jj. J Med Chem. 1986 Aug;29(8):1413-7. doi: 10.1021/jm00158a016. J Med Chem. 1986. PMID: 3016266

6

Adrenergic and dopaminergic properties of dopamine sulfoconjugates.

Kyncl JJ, Buckner SA, Brondyk H, Kerkman DJ, DeBernardis JF, Bush EN, Kuchel O. Kyncl JJ, et al. J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1198-204. doi: 10.1097/00005344-198511000-00030. J Cardiovasc Pharmacol. 1985. PMID: 2418311

7

Differentiation of alpha-adrenergic receptors using pharmacological evaluation and molecular modeling of selective adrenergic agents.

Hancock AA, Kyncl JJ, Martin YC, DeBernardis JF. Hancock AA, et al. Among authors: kyncl jj. J Recept Res. 1988;8(1-4):23-46. doi: 10.3109/10799898809048976. J Recept Res. 1988. PMID: 2898529

8

A new nasal decongestant, A-57219: a comparison with oxymetazoline.

DeBernardis JF, Winn M, Kerkman DJ, Kyncl JJ, Buckner S, Horrom B. DeBernardis JF, et al. Among authors: kyncl jj. J Pharm Pharmacol. 1987 Sep;39(9):760-3. doi: 10.1111/j.2042-7158.1987.tb06989.x. J Pharm Pharmacol. 1987. PMID: 2445950

9

Novel adrenergic compounds. I. Receptor interactions of ABBOTT-54741 [(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthtyl)imidazoline], an alpha-adrenergic agonist.

Kyncl JJ, DeBernardis JF, Bush EN, Buckner SA, Brondyk H. Kyncl JJ, et al. J Cardiovasc Pharmacol. 1989 Mar;13(3):382-91. doi: 10.1097/00005344-198903000-00005. J Cardiovasc Pharmacol. 1989. PMID: 2471883

10

Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains.

Winn M, Arendsen D, Dodge P, Dren A, Dunnigan D, Hallas R, Hwang K, Kyncl J, Lee YH, Plotnikoff N, Young P, Zaugg H. Winn M, et al. J Med Chem. 1976 Apr;19(4):461-71. doi: 10.1021/jm00226a003. J Med Chem. 1976. PMID: 817021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page